Product Information
MORPHINE SULFATE ER 20 MG CAP is a generic product labeled by Upsher-Smith Laboratories LLC, priced at $3.0808 per EA under NDC 00832022600. Its NADAC has been published 642 times since Mar 12, 2014.
Strength
20 mg/1
Manufacturer
Upsher-Smith Laboratories LLCNDC
00832022600
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
MORPHINE SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA202104On Market Since
6/30/2013
Pharmacological Classes
Price Statistics
The NADAC for MORPHINE SULFATE ER 20 MG CAP has been published 642 times since Mar 12, 2014, and over the history we have for it it has declined 23.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.0808 per EA |
|---|---|
| All-time high | $4.5120 (Aug 12, 2015) |
| All-time low | $1.4058 (Feb 19, 2020) |
| 52-week high | $3.3960 |
| 52-week low | $2.9419 |
| Median price | $3.0116 |
| Average price | $3.0073 |
| Largest weekly change | +111.1% (Oct 21, 2020) |
| Weeks tracked | 642 |
| Tracking since | Mar 12, 2014 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Morphine Sulfate market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of MORPHINE SULFATE ER 20 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for MORPHINE SULFATE ER 20 MG CAP, manufactured by Upsher-Smith Laboratories LLC, is $3.0808 per EA (NDC 00832022600), effective Jun 24, 2026.
How has the price of MORPHINE SULFATE ER 20 MG CAP changed over time?
Over the history we have for it, the NADAC for MORPHINE SULFATE ER 20 MG CAP has declined 23.5%. It has been tracked across 642 weekly CMS publications since Mar 12, 2014.
What are the highest and lowest recorded NADAC prices for MORPHINE SULFATE ER 20 MG CAP?
Since Mar 12, 2014, the NADAC for MORPHINE SULFATE ER 20 MG CAP has ranged from a low of $1.4058 (Feb 19, 2020) to a high of $4.5120 (Aug 12, 2015), with a median of $3.0116 per EA.
Are there cheaper alternatives to MORPHINE SULFATE ER 20 MG CAP?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of MORPHINE SULFATE ER 20 MG CAP, so no direct lower-cost alternative is listed.
Who manufactures MORPHINE SULFATE ER 20 MG CAP?
MORPHINE SULFATE ER 20 MG CAP (NDC 00832022600) is labeled by Upsher-Smith Laboratories LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification